Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pamela DiPiro, M.D.

Concepts (192)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Referral and Consultation5202336200.900 Why?
Oncology Service, Hospital22017560.670 Why?
Carcinoma, Lobular220204800.590 Why?
Abdominal Neoplasms120192870.560 Why?
Physician Assistants120181900.510 Why?
Breast Neoplasms182023212060.510 Why?
Mammography12201824330.500 Why?
Radiology4202321040.440 Why?
Neoplasms, Second Primary2201910610.430 Why?
Fibrocystic Breast Disease520001030.410 Why?
Tomography, X-Ray Computed132023207600.400 Why?
Biopsy, Needle8200016220.360 Why?
Academic Medical Centers5202327840.350 Why?
Lymphoma, Large B-Cell, Diffuse2201714370.310 Why?
Breast8200019760.300 Why?
Radiology Information Systems320215330.290 Why?
Cancer Care Facilities220184270.290 Why?
Inflammatory Breast Neoplasms220201500.290 Why?
Lymphoma, T-Cell120093080.270 Why?
Medical Oncology1201823460.260 Why?
Liver Neoplasms2202043620.260 Why?
Neoplasm Metastasis3201649120.250 Why?
Evidence-Based Medicine1201737060.240 Why?
Radiology Department, Hospital220194090.220 Why?
Ultrasonography, Mammary520182430.210 Why?
Magnetic Resonance Imaging72021367430.200 Why?
Genes, erbB-2220141620.200 Why?
Carcinoma, Ductal, Breast5202010990.190 Why?
Stereotaxic Techniques520005530.190 Why?
Fluorodeoxyglucose F182202020550.180 Why?
Forms and Records Control120201580.160 Why?
Incidental Findings220206980.150 Why?
Calcinosis5200014810.150 Why?
Multiple Pulmonary Nodules120201750.150 Why?
Calcium Phosphates120181730.140 Why?
Surgical Instruments119993810.140 Why?
Solitary Pulmonary Nodule120202820.140 Why?
Workload120028490.140 Why?
Environment1200211210.130 Why?
Retrospective Studies182023817620.130 Why?
Tumor Burden2201419060.130 Why?
Neoplasms52017223710.130 Why?
Lung Neoplasms62020135860.130 Why?
Quality Improvement3202038570.120 Why?
Foreign Bodies119994030.120 Why?
Seat Belts11995600.120 Why?
Immunoconjugates120239750.120 Why?
Humans5020237681660.120 Why?
Patient Care Planning120209050.120 Why?
Positron-Emission Tomography4201766690.110 Why?
Neoplasm Recurrence, Local4201794190.110 Why?
Receptors, Progesterone2202011600.110 Why?
Female3720233971920.100 Why?
Terminology as Topic1202015420.100 Why?
Clinical Protocols1201814430.100 Why?
Radiopharmaceuticals2202027350.100 Why?
Carcinoma, Intraductal, Noninfiltrating119999340.100 Why?
Receptor, erbB-23202326030.090 Why?
Receptors, Estrogen2202022530.090 Why?
Genes, BRCA1120147550.090 Why?
Interprofessional Relations120179970.090 Why?
Mucous Membrane120136590.090 Why?
Quinazolines2201413730.090 Why?
Breast Diseases319984420.090 Why?
Immunoblastic Lymphadenopathy12009400.080 Why?
Pleural Neoplasms120146120.080 Why?
Prognosis42019300100.080 Why?
Accidents, Traffic119958180.080 Why?
Survival Analysis22019101010.080 Why?
Contrast Media3201853300.080 Why?
Leukemia-Lymphoma, Adult T-Cell120091680.080 Why?
Neoplasm Staging72020112440.070 Why?
Pulmonary Embolism2201225990.070 Why?
Middle Aged2520202234920.070 Why?
Delivery of Health Care, Integrated120169510.070 Why?
Lymphoma, Large-Cell, Anaplastic120091680.070 Why?
Aged2120201715040.070 Why?
Nose Neoplasms120092500.070 Why?
Follow-Up Studies62020393480.070 Why?
Decision Support Techniques1201720080.070 Why?
Hodgkin Disease1201413840.070 Why?
Patient-Centered Care1201714440.070 Why?
Cone-Beam Computed Tomography120104590.070 Why?
Central Nervous System Neoplasms120149280.060 Why?
Adult2120202236460.060 Why?
Molecular Targeted Therapy1201728300.060 Why?
Melanoma2201457060.060 Why?
Diabetes Mellitus, Type 11199934470.060 Why?
Uterine Cervical Neoplasms1201620430.060 Why?
Carcinoma, Non-Small-Cell Lung2201454320.060 Why?
Carcinoma in Situ220007880.050 Why?
Aged, 80 and over92019596290.050 Why?
Antineoplastic Combined Chemotherapy Protocols22014118780.050 Why?
Radiation Injuries1201011980.050 Why?
Boston3201993740.050 Why?
Brachytherapy1201012200.050 Why?
Physicians1202045980.050 Why?
Mass Screening1201854580.050 Why?
Bone Neoplasms1201425650.050 Why?
Iohexol220142050.050 Why?
Radiography2202369830.050 Why?
Brain Neoplasms1202391180.050 Why?
Diagnosis, Differential32020130140.050 Why?
Camptothecin120236000.040 Why?
Gastrointestinal Stromal Tumors120056170.040 Why?
Antineoplastic Agents32017136760.040 Why?
Medical Record Linkage120192860.040 Why?
Radiographic Image Enhancement220148770.040 Why?
Workflow120228600.040 Why?
Treatment Outcome72023653710.040 Why?
Ultrasonography, Interventional2200215230.030 Why?
Negotiating120181520.030 Why?
Carcinoma, Squamous Cell1201240580.030 Why?
Radiographic Magnification11996180.030 Why?
Male1120173647190.030 Why?
Fibroadenoma11996420.030 Why?
Axilla120186230.030 Why?
Comprehensive Health Care120161230.030 Why?
Fat Necrosis11995600.030 Why?
Adenocarcinoma1201263950.030 Why?
Contusions11995780.030 Why?
Risk2201896130.030 Why?
Piperazines1200525540.030 Why?
Radiography, Interventional2199911310.030 Why?
Evaluation Studies as Topic1199616270.030 Why?
Data Collection1200233270.030 Why?
Pyrimidines1200530480.030 Why?
Antibodies, Neoplasm120142830.030 Why?
Lymph Node Excision1201812710.030 Why?
Models, Organizational120165480.030 Why?
Cysts119976850.020 Why?
Vinblastine120134870.020 Why?
Kaplan-Meier Estimate2201265260.020 Why?
Markov Chains120149790.020 Why?
Maytansine12011880.020 Why?
Mastectomy, Segmental119969740.020 Why?
Radiotherapy, Adjuvant1199617910.020 Why?
Biopsy2199967930.020 Why?
Mastectomy1201818610.020 Why?
Chemotherapy, Adjuvant1201835560.020 Why?
Ultrasonography2200060040.020 Why?
Estrogen Replacement Therapy1199612090.020 Why?
Skin Neoplasms1200958630.020 Why?
Vacuum22000650.020 Why?
Lymphocytes, Tumor-Infiltrating1201411050.020 Why?
Life Expectancy1201412480.020 Why?
Risk Factors12014749440.020 Why?
Neoadjuvant Therapy1201829070.020 Why?
Statistics, Nonparametric1201228620.020 Why?
Prospective Studies22023549260.020 Why?
Angiogenesis Inhibitors1201720560.020 Why?
Drug Administration Schedule1201448600.020 Why?
Lymphatic Metastasis1201329140.020 Why?
Radiation Dosage1201419670.020 Why?
Massachusetts1201888900.020 Why?
Cohort Studies22023417540.020 Why?
Decision Making1201839530.010 Why?
Observer Variation1201026220.010 Why?
Neovascularization, Pathologic1201426310.010 Why?
Survivors1201423810.010 Why?
Time Factors21996402180.010 Why?
Outpatients1201116000.010 Why?
Lymph Nodes1199334740.010 Why?
Dose-Response Relationship, Drug12014107600.010 Why?
Diagnostic Imaging1201635330.010 Why?
Cross-Sectional Studies12002263790.010 Why?
Cost-Benefit Analysis1201455360.010 Why?
Sex Factors12014106320.010 Why?
Biomedical Research1201634630.010 Why?
Recurrence1201285090.010 Why?
Early Detection of Cancer1201432390.010 Why?
Benzamides1200513790.010 Why?
Venous Thromboembolism1201218830.010 Why?
Multivariate Analysis12012120770.010 Why?
Automation120005890.010 Why?
Protein Kinase Inhibitors1201457030.010 Why?
Age Factors12014184120.010 Why?
Smoking1201490920.010 Why?
Hyperplasia1200011510.010 Why?
Image Processing, Computer-Assisted1201490150.010 Why?
Imaging, Three-Dimensional1201040630.010 Why?
Antibodies, Monoclonal1201492630.010 Why?
Anticoagulants1201248520.010 Why?
Reproducibility of Results12014202270.010 Why?
Chi-Square Distribution1200034360.010 Why?
Equipment Design1200035220.010 Why?
Incidence12011215380.010 Why?
Neoplasm Invasiveness1200036200.010 Why?
Lung12010100990.010 Why?
Young Adult12011600660.000 Why?
Case-Control Studies11997222910.000 Why?
Adolescent12005891690.000 Why?
DiPiro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (192)
Explore
_
Co-Authors (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.